Assuming you are a VC investor in healthcare. Let me know which of these two email templates below interests you the most if any.

Dear David

We have a unique approach to cancer drug discovery that will reduce timelines for cancer treatment developments by enhancing access to critical research and data. Current delays in information impact the timing of drugs which will mean life or death for millions of people each year. Most innovative cancer drugs are facing delays in reaching patients, because regulators are not keeping up with the pace of progress along with the shortage of human resources leading to delays from patent to patients, for current cancer patients a delay of just a few weeks could mean life or death.

We are solving this issue by building a platform where researchers and scientists freely exchange ideas, data, and information related to cancer. This unrestricted access removes barriers and allows specialists from diverse fields to build on each other’s work,

I would like an opportunity to have a call with you and show you how this works

How about this Thursday at 3:30 pm?

Emmanuel.

Vs

Subj: Seek advice

Hello Mr/Mrs X

The current landscape of cancer treatment development is marked by significant delays, jeopardizing the lives of millions of patients. The challenges, ranging from regulatory hurdles to resource shortages, have prompted us to devise a unique approach that accelerates the exchange of crucial research and data among scientists and researchers.

By creating an environment that fosters open collaboration, which no one is doing, we break down barriers and expedite the journey from patent to patients allowing scientists to build on each other’s work. This is especially crucial for cancer patients, where even a brief delay could be a matter of life or death.

Our approach has the potential to make a substantial impact on the timely delivery of groundbreaking cancer treatments.

The purpose of this message is to ask for an opportunity to meet you and show how this works How about this Thursday at 3:30 pm?

Emmanuel

  • ron_leflore@alien.topB
    link
    fedilink
    English
    arrow-up
    1
    ·
    10 months ago

    You need to include what exactly you are asking.

    This could be an email to convince the recipient to join your platform. VC will be like, I’m not a scientist, this is spam. Ignore.

    Just say you are raising $X and want him/her to invest. $X might be too small, or too large, for him/her to be interested. Don’t waste their time.

    • improvemental@alien.topOPB
      link
      fedilink
      English
      arrow-up
      1
      ·
      10 months ago

      What do you think of this?

      Hi David,

      We have a novel approach to cancer treatment discovery that reduces cancer drug development timeline by almost 90% speed-to-market. Most innovative cancer drugs are facing delays in reaching patients Due to regulators not being able to keep up with the pace of progress, the most exciting new therapies have not been successfully fast-tracked in an industry where a weeks delay can mean life or death for hundreds of thousands of people.

      Our approach is facilitating global collaboration between pharmaceutical companies in countries with strict and lengthy treatment adoption processes with those with lower and friendlier restrictions, reducing the process from the typical 10 -13 years to 1-2 years in the time of adoption. This has been validated by the WHO approach to the COVID response. Over 21 million people benefit from this process yearly in a global market of about $180 billion.

      We are seeking a $50,000 investment and I would love for the opportunity to walk you through our platform. I would like to opportunity to show you how this works over a Zoom call, Please let me know what day and time this week works best for you.

      Best,

      Emmanuel.

  • No_Importance_2338@alien.topB
    link
    fedilink
    English
    arrow-up
    1
    ·
    10 months ago

    Mention your unique approach right at the beginning to create immediate interest. The closing could be a bit more concise.

    • improvemental@alien.topOPB
      link
      fedilink
      English
      arrow-up
      1
      ·
      10 months ago

      Thanks for the feedback, what do you think of this?

      Hello Mr David,

      we’re building an open-source cancer drug and treatment discovery platform, that centralizes data, and human resources and fosters global collaboration by providing bounty incentives for experts, leading to improvements in drug discovery timelines, better data centralization, and a reduction in research redundancy, The global market for it is at $205.52 billion and we have a unique niche positioning with a clear revenue stream, Warm regards,

      I thought you would be interested in hearing our story because of your experience at X. If you have 15 minutes, I would love to show you our product over Zoom or we can also continue this over email.

      Warm regards, Emmanuel

  • tony-berg@alien.topB
    link
    fedilink
    English
    arrow-up
    1
    ·
    10 months ago

    By creating an environment that fosters open collaboration,

    That sounds like extra work, for people already very busy.

    which no one is doing,

    In most cases, especially in well established fields, there’s a reason why certain things aren’t being done. Ranging from that it can’t be done, perhaps for legal reasons, all the way to the people involved straight up resisting any form of changes to their current tools and routines.

    we break down barriers and expedite the journey from patent to patients allowing scientists to build on each other’s work.

    That sounds like extra work, and it sounds like something five out of four legal advisors will shutdown at a very early stage. (Because in healthcare and IP there’s a surplus of 'em.)

    All in all I’d expect anyone that could get interested to want to know a lot more before wanting to book a meeting.

    Ideally your message should be a lot shorter. Like a short tl;dr, followed by a pitch deck that actually works inline in that same email (on a small phone as well as a laptop).

    We’re talking 2-3 very short sentences that instantly tell the reader “we do this revolutionary thing”, followed by a deck that clearly show what you’ve got.

    At each stage you get more and more time before you lose your audience before they get to whatever point it is that you’re trying to make, but it starts at almost zero time. It starts with the subject line to even get them to open your email, and then you only get those first few sentences to convince them to not go with the default action of deleting yet another spam/cold email. Each stage is a sales pitch just to get them to the next stage, where you get a little bit more time before you lose them.

    The purpose of this message is to ask for an opportunity to meet you and show how this works How about this Thursday at 3:30 pm?

    Personally my default reaction to a too specific date and time is a no, simply because odds are that I can’t instantly commit with a yes.

    I tend to react more positively to questions that I can’t easily answer before mentally having come up with the answer that the other person want, like asking me when it at the earliest would be the most convenient for me to do a quick meeting.

    • improvemental@alien.topOPB
      link
      fedilink
      English
      arrow-up
      1
      ·
      10 months ago

      u/No_Importance_2338 appreciate the feedback, what do you both think of this?

      Hi David,

      We developed a method of finding cancer treatments that shortens the time needed to create new drugs by over 90% compared to the usual speed-to-market. The majority of novel cancer treatments are taking longer to get to patients. The most promising new treatments have not been effectively fast-tracked because regulators have not been able to keep up with the rate of advancement. In this business, a few weeks’ delay can mean the difference between life and death for hundreds of thousands of people.

      Our goal at MedAI is to reduce the average 10–13-year treatment adoption process to 1-2 years by facilitating collaboration between pharmaceutical companies in countries with severe and lengthy treatment adoption processes and those with fewer and accommodating limitations.

      This method benefits around 21 million people each year in a global market worth approximately $180 billion.

      I would like to opportunity to show you how this works over a Zoom call, Please let me know what day and time this week works best for you.

      Best,

      Emmanuel.

  • captaing1@alien.topB
    link
    fedilink
    English
    arrow-up
    1
    ·
    10 months ago

    this is too long. try the following.

    We have a new way to discover cancer medications (explain new way in maybe 4-5 words). It will reduce time to discover medicines by oxy (or whatever metric). This has been validated by xyz. We are going to save 20 millions lives in a global 60 billion market (or whatever the number is).

    If you are around for a 15 minute, I would love to show this to you because (he has exit or investment or whatever, you are trying to show you did your due diligence on him). We can also continue this over email.

    Keep it short. Keep it direct, keep it simple.

    • improvemental@alien.topOPB
      link
      fedilink
      English
      arrow-up
      1
      ·
      10 months ago

      Please let me know what you think of this.

      Hi David

      We have developed a revolutionary strategy for cancer treatment discovery that cuts the normal speed-to-market of cancer drugs by over 90%. Most novel cancer treatments are experiencing delays in reaching patients. The most promising new therapies have not been effectively fast-tracked due to regulators’ inability to keep up with the rate of research, and this is an industry where a week’s delay can mean life or death for hundreds of thousands of people.

      At AccelerateOncology, our objective is to facilitate collaboration between pharmaceutical companies in countries with severe and lengthy treatment adoption processes and those with less and more accommodating constraints, decreasing the process from 10 -13 years to 1-2 years in time of adoption.

      This method benefits around 21 million people each year in a global market worth approximately $180 billion.

      If you are around for 15 minutes, I would love to show this to you had an exit at X, We can also continue this over email.

      Best, Emmanuel